# A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia

> **NCT04694820** · NA · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 30 (actual)

## Conditions studied

- Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Chronic Phase Chronic Myelogenous Leukemia

## Interventions

- **OTHER:** Text Message-Based Navigation Intervention
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT04694820
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-05
- **Primary completion:** 2022-04-08
- **Final completion:** 2022-04-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04694820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04694820, "A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04694820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*